Zucara Therapeutics Revenue

Biotechnology Research • 661 University Ave, 1300, Canada • 11-20 Employees

Zucara Therapeutics revenue & valuation

Annual revenue	$6,500,000
Revenue per employee	$591,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$20,800,000
Total funding	$27,000,000

Key Contacts at Zucara Therapeutics

Michael Midmer

Chief Executive Officer

Richard Liggins

Co Founder & Chief Scientific Officer

Susan Peers

Directory, Clinical & Regulatory Affairs

Company overview

Headquarters	661 University Ave, 1300, Toronto, Ontario M5G 1M1, CA
Website	zucara.ca
NAICS	541714
SIC	283
Keywords	Diabetes, Hypoglycemia, Drug Therapy, Insulin
Founded	2015
Employees	11-20
Socials

Zucara Therapeutics Email Formats

Zucara Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@zucara.ca), used 83.3% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@zucara.ca	83.3%
{last name}{last name}	doedoe@zucara.ca	16.7%

About Zucara Therapeutics

Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent hypoglycemia in people with T1D and insulin-dependent Type 2 diabetes. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that impairs the glucagon response to hypoglycemia in people with these conditions. ZT-01 is designed to restore glucagon secretion to prevent hypoglycemia, which could dramatically change diabetes disease management and improve both patient health and quality of life. For more information, visit www.zucara.ca.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Manager

C-Suite

Director

Employees by Department

Zucara Therapeutics has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Zucara Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-07-15	9	$2,000,000
2024-12-12	5	$20,000,000
2025-06-01	5	$5,000,000

Funding Insights

$27,000,000

Total funding amount

$5,000,000

Most recent funding amount

Number of funding rounds

Zucara Therapeutics Tech Stack

Discover the technologies and tools that power Zucara Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Slider Revolution

Photo galleries

Contact Form 7

Form builders

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

core-js

JavaScript libraries

Google Analytics

Analytics

MySQL

Databases

RSS

Miscellaneous

Frequently asked questions

Zucara Therapeutics is located in 661 University Ave, 1300, CA.

Zucara Therapeutics generates an estimated annual revenue of $6,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Zucara Therapeutics has an estimated valuation of $20,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Zucara Therapeutics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

Zucara Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Zucara Therapeutics has raised a total of $27,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.